Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article Report
  • Published:

Authors’ response to “Drug Insight: aspirin resistance—fact or fashion?”

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Patrono C and Rocca B (2007) Drug insight: aspirin resistance: fact or fashion? Nat Clin Pract Cardiovasc Med 4: 42–50

    Article  CAS  Google Scholar 

  2. Maree AO et al. (2005) Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease. J Am Coll Cardiol 46: 1258–1263

    Article  CAS  Google Scholar 

  3. Reilly IA and FitzGerald GA (1987) Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Blood 69: 180–186

    Article  CAS  Google Scholar 

  4. FitzGerald GA et al. (1983) Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest 71: 676–688

    Article  CAS  Google Scholar 

  5. Fontana P et al. (2006) Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers. J Thromb Haemost 4: 813–819

    Article  CAS  Google Scholar 

  6. Cox D et al. (2006) Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. Stroke 37: 2153–2158

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlo Patrono.

Ethics declarations

Competing interests

Carlo Patrono received lecture and consulting fees for AstraZeneca, Bayer AG, Eli Lilly, Nicox, Sanofi-Aventis and Servier. Bianca Rocca has received lecture fees from Nycomed.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patrono, C., Rocca, B. Authors’ response to “Drug Insight: aspirin resistance—fact or fashion?”. Nat Rev Cardiol 4, E2 (2007). https://doi.org/10.1038/ncpcardio0835

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpcardio0835

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing